Navigation Links
Pharmaceutical Product Commercialization: Enabling Teams to Excel
Date:11/9/2007

CHAPEL HILL, N.C., Nov. 9 /PRNewswire/ -- Pharmaceutical product teams have the power to make or break the launch of a new product. The problem is launch teams often lack the right structure, tools and processes to run effectively and therefore only produce a sub-optimal launch.

In fact, pharmaceutical marketing and HR executives agree that collaborative behavior and cross-functional team work are key ingredients during product commercialization. According to a study by pharmaceutical benchmarking firm Best Practices, LLC, many organizations still use fully operational cross-functional teams too infrequently.

Cross-function collaboration is greatly improved through many methods -- structuring jobs with overlapping responsibilities, basing rewards on group performance, designing procedures so that employees with different jobs are better able to collaborate, and laying out work areas so that people can see one another's work and share lessons learned.

"Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence," available with a complimentary study summary online at http://www3.best-in-class.com/rr878.htm, provides extensive insight into how pharmaceutical, biotech and medical device companies are building team communication and leadership structures that prepare employees to excel in a competitive marketplace.

Valuable best practices and operating tactics were gathered from leading pharmaceutical companies, including Amgen, Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Procter & Gamble, Roche, Sanofi-Aventis and Wyeth. They will help executives build and manage strong teams that can excel across functions, units and regions.

-- One benchmark partner aligned clinical and commercial's compensation,

bonuses and evaluation
'/>"/>

SOURCE Best Practices, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- ,Middle-aged adults with ... as likely as others to develop severe memory problems ... The British researchers said their findings could help doctors ... benefit from help for problem drinking. "We already ... levels of current alcohol consumption -- that understanding is ...
(Date:7/30/2014)... July 30, 2014 Florida A&M ... Renee Gordon and biochemistry professor Ngozi Ugochukwu, Ph.D., ... research as Fulbright Scholars. The prestigious Fulbright Scholars ... program that awards grants to students, faculty or ... research abroad. Both Gordon and Ugochukwu will conduct ...
(Date:7/30/2014)... 30, 2014 In today’s world, a good ... get. Snoring and sleep apnea (a medical problem where the ... their bed partners of the rest they need to face ... population snores and 20 million people in the United States ... diagnosed and treated; and of those treated, many cannot tolerate ...
(Date:7/30/2014)... NC (PRWEB) July 30, 2014 Chinese researchers ... mass in blood plasma can be used as a prognostic ... Click here to read the full article on the study ... Scientists in the Department of Respiratory Medicine at Shandong University ... diagnosed mesothelioma patients between 1995 and 2013. They ...
(Date:7/30/2014)... York, NY (PRWEB) July 30, 2014 ... chiropractor Dr Steven Shoshany aims to help runners ... proven techniques to help athletes continue training. He has ... chiropractic, ART (Active Release Techniques), Cold Laser Therapy, Graston ... and injury free. , Dr Shoshany often combines ...
Breaking Medicine News(10 mins):Health News:Adults Who've Abused Alcohol May Be at Risk for Memory Problems 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Study Finds Common Blood Protein May Predict Mesothelioma Survival, Reports Surviving Mesothelioma 2Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 2Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 3
... WASHINGTON, June 9 Speaker Nancy Pelosi today ... Chairman Charles B. Rangel, Energy and Commerce Committee Chairman ... Miller briefed the Democratic Caucus on their draft health ... of doctors and plans, and guarantee affordable, quality health ...
... it,s no better than standard treatment, one expert says, ... the indigestion and heartburn that bother many women as ... Indigestion is common during pregnancy, with up to 80 ... reflux, belching and bloating. Symptoms tend to worsen over ...
... - Europe Cosmetiques and Probiox announced today that both ... respect to oxidative stress profiling. Under this agreement, Europe ... and Mexico. , According to Manon Pilon, Founder President ... the leader in the Medical SPA industry, and is ...
... 9 Allied World Assurance,Company (U.S.) Inc., a member ... AWH ), today announced an added service to ... States. The,complimentary service, called "Strategic Response(SM)," provides policyholders,with 24/7 ... of a catastrophe. , Gordon ...
... Calif., June 9 Jazz Pharmaceuticals, Inc. (Nasdaq: ... company,s first Phase III clinical trial of sodium oxybate ... this week during the Associated Professional Sleep Societies (APSS) ... the European League Against Rheumatism (EULAR) Congress in Copenhagen, ...
... , Programs Designed to Address High Risks for New Dialysis ... , DENVER, June 9 DaVita Inc. (NYSE: ... for those diagnosed with chronic kidney disease (CKD), today commended ... in Kidney Care (PEAK) campaign. Kidney Care Partners - ...
Cached Medicine News:Health News: Acupuncture May Relieve Heartburn In Pregnancy 2Health News: Acupuncture May Relieve Heartburn In Pregnancy 3Health News:"Alliance between Europe Cosmetiques and Probiox brings new oxydative stress profiling technologies to North America" 2Health News:Allied World U.S. Announces Strategic Response(SM) - Complimentary Service Added to General Liability Lead Umbrella Product 2Health News:Allied World U.S. Announces Strategic Response(SM) - Complimentary Service Added to General Liability Lead Umbrella Product 3Health News:Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia 2Health News:Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia 3Health News:Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia 4Health News:DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 2Health News:DaVita Commends Kidney Care Partners for Launch of PEAK Campaign 3
(Date:7/30/2014)... SANTA CLARA, Calif. , July 30, 2014 /PRNewswire/ ... innovation economy, released a study today that ... venture-backed biopharma and medical device companies.  According to the ... healthcare saw the biggest potential returns since SVB started ... the year of the IPO.  Built on solid healthcare ...
(Date:7/30/2014)... -- Packaging Coordinators, Inc. (PCI) is pleased to announce it ... Services Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... United Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug ... form manufacturing, as well as Clinical Packaging, Labeling, and ...
(Date:7/30/2014)... /PRNewswire-iReach/ -- This is a professional and in-depth ... (CAS 9041-08-1) & calcium (CAS 37270-89-6) industry. The ... sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) including ... then explores global and China,s top manufacturers of ... listing their product specification, capacity, production value, cost, ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5
... Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ), ... and gastroenterology markets, today announced that Rick S. Greene, ... appointed interim Vice President, Finance & Accounting effective April ... of experience in financial management and reporting.  He previously ...
... 4, 2011 PLC Systems Inc. (OTCBB: PLCSF), ... announced that final results from the REMEDIAL II ... presented today. The results showed that RenalGuard was ... care at preventing Contrast-Induced Nephropathy (CIN) and Dialysis ...
Cached Medicine Technology:Cumberland Pharmaceuticals Appoints Rick S. Greene as Vice President, Finance & Accounting 2Cumberland Pharmaceuticals Appoints Rick S. Greene as Vice President, Finance & Accounting 3REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care 2REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care 3REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care 4
Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
... The Criterion Dodeca cell, a component of ... run up to 12 Criterion gels in a ... (13.3 x 8.7 cm) than the traditional mini ... strips to give you the optimal combination of ...
... Plus Dodeca cell accommodates up to 12 ... first-dimension runs in the PROTEAN IEF system, ... format. The PROTEAN Plus Dodeca cell's cooling ... electrodes, allow consistent, high-resolution results. The handcasting ...
... The ElectroXpress gel electrophoresis system mirrors a ... high-throughput screening of PCR products to take ... the source (96-well) plate. Loading can be carried ... the first time in the industry two ...
Medicine Products: